Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/5zjg-0e42

technical paper

ENDO 2021

March 21, 2021

Live on Underline

Enzalutamide Downregulates TMPRSS2 in Lung Cells and Reduces Cellular Entry of SARS-CoV-2

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

Persistent and stable growth promoting effects of vosoritide in children with achondorplasia for up to 2 years: Results from the ongoing Phase 3 extension study
technical paper

Persistent and stable growth promoting effects of vosoritide in children with achondorplasia for up to 2 years: Results from the ongoing Phase 3 extension study

ENDO 2021

21 March 2021

Similar lecture

Clinical Guidance for Patients with Adrenal Insufficiency During COVID-19 Pandemic
technical paper

Clinical Guidance for Patients with Adrenal Insufficiency During COVID-19 Pandemic

ENDO 2020

Priscila Sales Barroso and 1 other author

10 June 2020

Stay up to date with the latest Underline news!

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved